GlassScriptPhysician profile
Steven K Brooks
NPI 1992868228
$16,486.70
in general payments reported to CMS, 2019-2025
51 companies · $3,037 in 2025
The $3,037 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,896 · 2020: $797 · 2021: $933 · 2022: $1,255 · 2023: $1,273 · 2024: $1,297 · 2025: $3,037.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,188 · Travel and Lodging: $247 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,188.47 |
| Travel and Lodging | $247.47 |
| Education | $169.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $7,030.65 | 2019-2022 | |
| Teleflex LLC | $1,240.42 | 2021-2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $1,085.59 | 2019-2025 | Aquabeam System, Aquabeam Robotic System |
| Coloplast Corp | $1,078.82 | 2019-2025 | Titan |
| Boston Scientific Corporation | $879.34 | 2019-2025 | Lumenis Pulse 120h, Greenlight Xps, Moses |
| Pfizer INC. | $504.80 | 2019-2025 | |
| Janssen Biotech, INC. | $428.42 | 2019-2025 | Erleada |
| Abbvie INC. | $302.39 | 2022-2025 | Botox, Lupron Depot |
| Urogen Pharma, INC. | $287.60 | 2021-2025 | |
| Axonics, INC. | $260.01 | 2022-2023 | Axonics |
| Sumitomo Pharma America, INC. | $245.03 | 2023-2025 | Orgovyx |
| Myovant Sciences INC. | $244.18 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $220.75 | 2025 | Adstiladrin |
| Profound Medical Corp. | $206.77 | 2025 | Tulsa-Pro |
| Lumenis, INC | $199.82 | 2019 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.